In particular, the emerging evidence related to the biological activity of SerpinB3 in tumor microenvironment is of relevance since it outlines two putative novel therapeutic targets involved in cell proliferation and HCC development and progression. Here, SERPINB3 is linked to hepatocellular carcinoma.